Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q3 EPS of $0.14, $0.07 better than the analyst estimate of $0.07. Revenue for the quarter came in at $106.86 million versus the consensus estimate of $102.07 million.

GUIDANCE:

Cellebrite DI Ltd. sees Q4 2024 revenue of $105-109 million, versus the consensus of $107 million.

For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.